US Bancorp’s Marker Therapeutics MRKR Stock Holding History

US Bancorp’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-839	Closed	-$2.61K	–	4308
2024 Q4	$2.61K	Hold	839	–	–	﹤0.01%	3805
2024 Q3	$2.37K	Hold	839	–	–	﹤0.01%	3746
2024 Q2	$4.56K	Hold	839	–	–	﹤0.01%	3546
2024 Q1	$3.61K	Hold	839	–	–	﹤0.01%	3601
2023 Q4	$4.62K	Hold	839	–	–	﹤0.01%	3551
2023 Q3	$3.81K	Hold	839	–	–	﹤0.01%	3511
2023 Q2	$2.6K	Hold	839	–	–	﹤0.01%	3634
2023 Q1	$596	Sell	839 -500	-37%	-$1.19K	﹤0.01%	3931
2022 Q4	$3.56K	Hold	1,339	–	–	﹤0.01%	3622
2022 Q3	$5K	Hold	1,339	–	–	﹤0.01%	3602
2022 Q2	$5K	Hold	1,339	–	–	﹤0.01%	3593
2022 Q1	$6K	Hold	1,339	–	–	﹤0.01%	3554
2021 Q4	$13K	Hold	1,339	–	–	﹤0.01%	3325
2021 Q3	$22K	Hold	1,339	–	–	﹤0.01%	3089
2021 Q2	$37K	Hold	1,339	–	–	﹤0.01%	2818
2021 Q1	$30K	Hold	1,339	–	–	﹤0.01%	2836
2020 Q4	$19K	Hold	1,339	–	–	﹤0.01%	2940
2020 Q3	$21K	Hold	1,339	–	–	﹤0.01%	2801
2020 Q2	$27K	Hold	1,339	–	–	﹤0.01%	2684
2020 Q1	$26K	Hold	1,339	–	–	﹤0.01%	2648
2019 Q4	$38K	Hold	1,339	–	–	﹤0.01%	2602
2019 Q3	$69K	Hold	1,339	–	–	﹤0.01%	2324
2019 Q2	$106K	Hold	1,339	–	–	﹤0.01%	2181
2019 Q1	$88K	Buy	+1,339	New	+$78.2K	﹤0.01%	2254
2018 Q4	–	Sell	-500	Closed	-$45K	–	3651
2018 Q3	$45K	Hold	500	–	–	﹤0.01%	2616
2018 Q2	$47K	Buy	+500	New	+$25.5K	﹤0.01%	2614

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AAM

AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

US Bancorp's MRKR Position: Q1 2025 in Review

US Bancorp sold out of Marker Therapeutics (MRKR) in Q1 2025, closing a stake of 839 shares — an estimated $2.61K sold.

US Bancorp first reported a position in MRKR in Q2 2018 and held it in 26 quarters. The position peaked at $106K in Q2 2019. 32 funds tracked by Wall St. Rank hold MRKR as of Q1 2025.

US Bancorp reported no remaining Marker Therapeutics position as of Q1 2025 after selling out during the quarter.
US Bancorp sold 839 Marker Therapeutics shares in Q1 2025, an estimated $2.61K.
US Bancorp first reported a position in Marker Therapeutics in Q2 2018 and held it in 26 quarters.
US Bancorp's Marker Therapeutics position peaked at $106K in Q2 2019.
32 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.